Viewing Study NCT02835833

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-27 @ 5:41 AM
Study NCT ID: NCT02835833
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2016-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
Sponsor: University of Alabama at Birmingham
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Colorectal Adenocarcinoma View
None Non-squamous Non-small Cell Lung Cancer View
None Platinum-refractory Ovarian Carcinoma View
None Cervical Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced solid tumors View
None Nintedanib View
None Bevacizumab View
None dose escalation View